Overview

Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers

Status:
Terminated
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study is conducted to compare and evaluate the effect of administering a high-dose intravenous proton pump inhibitors or high-dose oral Rabeprazole in preventing recurrent bleeding after the endoscopic treatment of bleeding peptic ulcers.
Phase:
Phase 4
Details
Lead Sponsor:
The Catholic University of Korea
Collaborator:
Janssen Korea, Ltd., Korea
Treatments:
Omeprazole
Rabeprazole